After the silencing of SNHG15, the expressions of E-cadherin and β-catenin were memorably increased, while the N-cadherin and Vimentin were decreased, suggesting that SNHG15 was also involved in the development of OSCC (59), bladder cancer (28), BC (54), and OC (63). The gene discussed is SNHG15; the disease is breast cancer.